167 related articles for article (PubMed ID: 1696634)
1. Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.
Bugge TH; Lindhardt BO; Hansen LL; Kusk P; Hulgaard E; Holmbäck K; Klasse PJ; Zeuthen J; Ulrich K
J Virol; 1990 Sep; 64(9):4123-9. PubMed ID: 1696634
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
3. A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
Cleveland SM; McLain L; Cheung L; Jones TD; Hollier M; Dimmock NJ
J Gen Virol; 2003 Mar; 84(Pt 3):591-602. PubMed ID: 12604810
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
5. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
Buratti E; Tisminetzky SG; D'Agaro P; Baralle FE
J Virol; 1997 Mar; 71(3):2457-62. PubMed ID: 9032383
[TBL] [Abstract][Full Text] [Related]
6. Expression in yeast of a cDNA clone encoding a transmembrane glycoprotein gp41 fragment (a.a. 591-642) bearing the major immunodominant domain of human immunodeficiency virus.
Gairin JE; Madaule P; Traincard F; Barrès E; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):109-19. PubMed ID: 1863470
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
[TBL] [Abstract][Full Text] [Related]
8. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1.
Stiegler G; Kunert R; Purtscher M; Wolbank S; Voglauer R; Steindl F; Katinger H
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1757-65. PubMed ID: 11788027
[TBL] [Abstract][Full Text] [Related]
9. Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.
Oldstone MB; Tishon A; Lewicki H; Dyson HJ; Feher VA; Assa-Munt N; Wright PE
J Virol; 1991 Apr; 65(4):1727-34. PubMed ID: 2002540
[TBL] [Abstract][Full Text] [Related]
10. An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement.
Eaton AM; Ugen KE; Weiner DB; Wildes T; Levy JA
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):13-8. PubMed ID: 7514015
[TBL] [Abstract][Full Text] [Related]
11. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
Cotropia J; Ugen KE; Kliks S; Broliden K; Broliden PA; Hoxie JA; Srikantan V; Williams WV; Weiner DB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):221-32. PubMed ID: 8673526
[TBL] [Abstract][Full Text] [Related]
12. Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
McLain L; Brown JL; Cheung L; Reading SA; Parry C; Jones TD; Cleveland SM; Dimmock NJ
Arch Virol; 2001; 146(1):157-66. PubMed ID: 11266210
[TBL] [Abstract][Full Text] [Related]
13. Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
Alsmadi O; Tilley SA
J Virol; 1998 Jan; 72(1):286-93. PubMed ID: 9420226
[TBL] [Abstract][Full Text] [Related]
14. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates.
Horal P; Svennerholm B; Jeansson S; Rymo L; Hall WW; Vahlne A
J Virol; 1991 May; 65(5):2718-23. PubMed ID: 1707985
[TBL] [Abstract][Full Text] [Related]
15. Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals.
Calarota S; Jansson M; Levi M; Broliden K; Libonatti O; Wigzell H; Wahren B
AIDS Res Hum Retroviruses; 1996 May; 12(8):705-13. PubMed ID: 8744581
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies.
Xu JY; Gorny MK; Palker T; Karwowska S; Zolla-Pazner S
J Virol; 1991 Sep; 65(9):4832-8. PubMed ID: 1714520
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
Sojar H; Baron S; Sullivan JT; Garrett M; van Haaren MM; Hoffman J; Overbaugh J; Doranz BJ; Hicar MD
J Virol; 2019 Sep; 93(17):. PubMed ID: 31217246
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro.
Robinson WE; Kawamura T; Gorny MK; Lake D; Xu JY; Matsumoto Y; Sugano T; Masuho Y; Mitchell WM; Hersh E
Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3185-9. PubMed ID: 2326277
[TBL] [Abstract][Full Text] [Related]
19. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.
Clerici M; Barassi C; Devito C; Pastori C; Piconi S; Trabattoni D; Longhi R; Hinkula J; Broliden K; Lopalco L
AIDS; 2002 Sep; 16(13):1731-41. PubMed ID: 12218383
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.
Prigent S; Goossens D; Clerget-Raslain B; Bahraoui E; Roussel M; Tsikas G; Laurent A; Montagnier L; Salmon C; Gluckman JC
AIDS; 1990 Jan; 4(1):11-9. PubMed ID: 2156527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
